IRESF:OTC-iShares Public Limited Company - iShares Core FTSE 100 UCITS ETF (USD)

ETF | Others |

Last Closing

USD 7.2957

Change

+0.02 (+0.23)%

Market Cap

N/A

Volume

5.69K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

+1.43 (+0.26%)

USD 32.85B
IISHF iShares III Public Limited Com..

N/A

USD 9.10B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
IHPCF iShares Public Limited Company..

+0.18 (+0.35%)

USD 8.93B
CUYTY Etablissementen Franz Colruyt ..

N/A

USD 7.56B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
BCYIF iShares Public Limited Company..

N/A

USD 5.80B
IIREF iShares Public Limited Company..

N/A

USD 5.32B
IHSXF iShares Public Limited Company..

+0.46 (+0.47%)

USD 4.14B
SSEEF SSgA SPDR ETFs Europe I Public..

-0.52 (-0.71%)

USD 2.95B

ETFs Containing IRESF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.88% 74% C 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.88% 75% C 63% D
Trailing 12 Months  
Capital Gain 8.17% 53% F 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.17% 53% F 67% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.68% 68% D+ 54% F
Dividend Return 8.68% 68% D+ 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.43% 69% C- 96% N/A
Risk Adjusted Return 83.22% 98% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike